| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |